Abstract:Insulin-like growth factor 2 messenger RNA-binding proteins have been described to associate with malignant process in many cancers. However, the role of insulin-like growth factor 2 messenger RNA-binding protein family has not been thoroughly elucidated in non–small cell lung cancer. This study was to investigate the expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins family in non–small cell lung cancer. The expression levels of IGF2BP1–IGF2BP3 in tumor and adjacent normal tissues were determined, and association with clinicopathological features and overall survival was investigated by analyzing The Cancer Genome Atlas lung cancer database. Proliferation, migration, invasion assays, and flow-cytometry analysis were used to investigate the biological function in vitro. Insulin-like growth factor 2 messenger RNA-binding protein expression levels were significantly increased in non–small cell lung cancer compared to adjacent normal lung tissues. Chi-square test indicated that IGF2BP1 and IGF2BP3 expressions correlated with some meaningful clinical characteristics in non–small cell lung cancer. Kaplan–Meier analysis showed that high-level expression of IGF2BP1 or IGF2BP3 predicted poor overall survival in lung adenocarcinoma patients. Multivariate regression analysis showed that high level of IGF2BP3 was an independent risk factor for poor prognosis in lung adenocarcinoma patients (hazard ratio = 1.616, p = 0.017). In vitro, knockdown of IGF2BP3 inhibited lung adenocarcinoma cell proliferation by inducing cell cycle arrest and apoptosis, and undermined abilities of migration and invasion, and overexpression of IGF2BP3 could promote malignant phenotypes in lung adenocarcinoma cells. Our study revealed that expression of insulin-like growth factor 2 messenger RNA-binding proteins was widely upregulated and correlated with some certain clinicopathological features in non–small cell lung cancer. Especially, in insulin-like growth factor 2 messenger RNA-binding protein family, IGF2BP3 might play the most important role in tumor aggressiveness and prognosis in lung adenocarcinoma, and IGF2BP3 might serve as a potential therapeutic target and a novel prognostic biomarker in lung adenocarcinoma patients.

Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC.

Interaction Between Epidermal Growth Factor Receptor and Interleukin-6 Receptor in NSCLC Progression

Interaction of estrogen receptor β5 and interleukin 6 receptor in the progression of non-small cell lung cancer.

Role of Insulin-Like Growth Factor 1 in Drug Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer

Up-Regulation of Insulin-Like Growth Factor-2 Promotes Cell Proliferation and Migration and is Associated with Bone Metastasis in Non Small Cell Lung Cancer.

Interstitial Tumor-Associated Macrophages Combined with Tumor-Derived Colony-Stimulating Factor-1 and Interleukin-6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer.

Effects of Insulin-Like Growth Factor 1 Receptor and Its Inhibitor AG1024 on the Progress of Lung Cancer

An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Expression and Clinical Significance of Insulin-Like Growth Factor 1 in Lung Cancer Tissues and Perioperative Circulation from Patients with Non-Small-cell Lung Cancer.

Clinical Significance of Combined Detection of Interleukin-6 and Tumour Markers in Lung Cancer

Expression Profile, Clinical Significance, and Biological Function of Insulin-Like Growth Factor 2 Messenger RNA-binding Proteins in Non–small Cell Lung Cancer

Insulin-Like Growth Factor Receptor 1 (Igf1r) Expression And Survival In Non-Small Cell Lung Cancer Patients: A Meta-Analysis

Prognostic Significance of IGF-1 Signaling Pathway in Patients with Advanced Non-Small Cell Lung Cancer

[Interleukin 7 and Its Receptor Promote Cell Proliferation and Induce Lymphangiogenesis in Non-Small Cell Lung Cancer].

The Correlation between IGF1,IGF2 Expression and Lymph Node Metastasis in Non-small Cell Lung Cancer

IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression

Association of Preoperative Serum Igf- I Concentration with Clinicopathological Parameters in Patients with Non-Small Cell Lung Cancer

Oncogenic Activity of Insulin in the Development of Non-Small Cell Lung Carcinoma

CD147-CD98hc Complex Contributes to Poor Prognosis of Non-Small Cell Lung Cancer Patients Through Promoting Cell Proliferation Via the PI3K/Akt Signaling Pathway

Expression Insulin-Like Growth Factor Binding Protein 3 in Non-Small Cell Lung Cancer